pharmaceutical investing KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug
pharmaceutical investing KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
Premier American Uranium Reports Results Following Annual General and Special Meeting of Shareholders
Nuvau Winter Drilling at Thundermine Returns 5.28 g/t Au over 6.1 m, Including 7.22 g/t Au over 3.1 m
